XML 20 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Capital in Excess of Par Value
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Noncontrolling Interests
Balance at beginning of period (shares) at Dec. 31, 2017   98,300          
Balance at beginning of period at Dec. 31, 2017 $ 1,395.4 $ 1.1 $ 2,747.4 $ (1,176.2) $ (1.3) $ (418.5) $ 242.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 361.5     292.3     69.2
Receipt of treasury stock (shares)   (200)          
Receipt of treasury stock (8.3)         (8.3)  
Dividends declared (103.7)   (103.7)        
Stock-based compensation 28.9   28.9        
Stock options exercised (shares)   100          
Stock options exercised 3.2   3.2        
Distributions declared (71.1)           (71.1)
Capital contributions from consolidated affiliates 38.8           38.8
Fair value adjustments to redeemable noncontrolling interests (91.0)   (91.0)        
Other (shares)   700          
Other 3.3   3.9 (1.3) 1.3 (1.1) 0.5
Balance at end of period (shares) at Dec. 31, 2018   98,900          
Balance at end of period at Dec. 31, 2018 1,557.0 $ 1.1 2,588.7 (885.2) 0.0 (427.9) 280.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 433.2     358.7     74.5
Receipt of treasury stock (shares)   (300)          
Receipt of treasury stock (16.6)         (16.6)  
Dividends declared (109.3)   (109.3)        
Stock-based compensation 32.4   32.4        
Stock options exercised (shares)   100          
Stock options exercised 1.4   1.4        
Distributions declared (70.2)           (70.2)
Repurchases of common stock in open market (in shares)   (800)          
Repurchases of common stock in open market (45.9)         (45.9)  
Capital contributions from consolidated affiliates 20.0           20.0
Fair value adjustments to redeemable noncontrolling interests (147.6)   (147.6)        
Consolidation of Yuma Rehabilitation Hospital 25.0           25.0
Other (shares)   700          
Other 13.7   4.3 0.0 0.0 (1.9) 11.3
Balance at end of period (shares) at Dec. 31, 2019   98,600          
Balance at end of period at Dec. 31, 2019 1,693.1 $ 1.1 2,369.9 (526.5) 0.0 (492.3) 340.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 361.4     284.2     77.2
Receipt of treasury stock (shares)   (200)          
Receipt of treasury stock (15.7)         (15.7)  
Dividends declared (111.6)   (111.6)        
Stock-based compensation $ 29.5   29.5        
Stock options exercised (shares) 50 100          
Stock options exercised $ 1.1   1.1        
Distributions declared (72.1)           (72.1)
Repurchases of common stock in open market (in shares)   (100)          
Repurchases of common stock in open market (6.1)         (6.1)  
Capital contributions from consolidated affiliates 42.8           42.8
Fair value adjustments to redeemable noncontrolling interests 1.4   1.4        
Exchange of Holdings shares (shares)   600          
Exchange of Holdings shares 46.3   27.1     19.2  
Other (shares)   400          
Other (0.1)   9.2     (2.5) (6.8)
Balance at end of period (shares) at Dec. 31, 2020   99,400          
Balance at end of period at Dec. 31, 2020 $ 1,970.0 $ 1.1 $ 2,326.6 $ (242.3) $ 0.0 $ (497.4) $ 382.0